ApolloBio Corporation

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • Beijing Apollo Venus Biomedical Technology.
See more in Biomedtracker

Latest on ApolloBio Corporation

Scrip

Inovio Abandons Lassa, MERS Vaccines Shortly After Ending COVID-19 Booster Work

 
• By Joseph Haas

Development setbacks continue for Inovio Pharmaceuticals, Inc. as the Philadelphia-area firm revealed on 17 November that it is ending development of a pair of vaccine candidates – INO-4500 for Lass

Scrip

Deal Watch: Opportunity Knocks For Partnerships In Asia

 
• By Joseph Haas, Sten Stovall, Anju Ghangurde, Kevin Grogan, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Scrip

Deal Watch: Pfizer Begins 2018 With Two Deals, Including ALS Tie-Up With Sangamo

 
• By Joseph Haas and Ying Huang

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

In Vivo

Deals Shaping The Medical Industry, March 2017

 
• By Steven Muntner, Beth Allan, Deanna Kamienski, Amanda Micklus, and Maureen Riordan

IN VITRO DIAGNOSTICS Financings Vermillion Inc. Vermillion Inc. grossed $5.6mm through the private sale of 3.75mm common shares at $1.40 (a 6% premium). Investors also received five-year warrants